Oridonin targets PRDX1 to promote apoptosis by inducing ROS-mediated ER stress and modulating autophagy
International Journal of Biological Sciences · 2026
DOI: 10.7150/ijbs.110208 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2026. Verfasst von Ziyang Ding und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of…. Hauptthemen laut MEDLINE: Diterpenes, Kaurane, Reactive Oxygen Species, Peroxiredoxins, Autophagy. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Oridonin is a bioactive diterpenoid derived from the widely used traditional Chinese medicinal herb Rabdosia rubescens, exhibits broad-spectrum anti-cancer activity, with several derivatives currently in clinical trials. However, the molecular mechanism underlying its anticancer effects, especially its direct target proteins, remain to be fully elucidated. Here, we found that Oridonin promoted intracellular reactive oxygen species (ROS) accumulation, which in turn induced endoplasmic reticulum (ER) stress-mediated apoptosis. Moreover, ER stress was instrumental in inducing autophagy after Oridonin treatment, while blockade of autophagy further exacerbated Oridonin-induced cytotoxicity. Notably, using activity-based protein profiling (ABPP), we identified the anti-oxidant enzyme Peroxiredoxin 1 (PRDX1) as a key direct covalent target of Oridonin. By binding to Cysteine 173 of PRDX1, Oridonin increased intracellular ROS levels. Furthermore, PRDX1 over-expression mitigated, whereas PRDX1 knockdown potentiated, Oridonin-induced ROS accumulation, autophagy, and subsequently apoptosis. Overall, our results indicate that PRDX1 is a direct covalent binding target mediating Oridonin-induced apoptosis. These findings not only provide fresh insights into the core mechanism of Oridonin-induced cytotoxicity, but also highlight PRDX1 as a potential therapeutic target for renal cancer drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
- Department of Critical Care Medicine, Guangdong Provincial Clinical Research Center for Geriatrics, Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital (The Second Clinical Medical College, Jina…
- Center for Drug Research and Development, Guangdong Provincial Key Laboratory for Research and Evaluation of Pharmaceutical Preparations, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, China.
- Department of Reproductive Medicine, Dongguan Maternal and Child Health Care Hospital, Dongguan, 523000, China.
- Mr. & Mrs. Ko Chi-Ming Centre for Parkinson's Disease Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China.
- Department of Biochemistry, Karpagam Academy of Higher Education, Coimbatore, India.
Zitieren
APA
Ding, Z., Wang, S., Chen, J., Song, Y., Zhu, Z., Tong, H., Iyaswamy, A., Chen, P., Wei, X., Zhang, W., Wang, J., Yang, C., & Feng, Y. (2026). Oridonin targets PRDX1 to promote apoptosis by inducing ROS-mediated ER stress and modulating autophagy. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.110208
Vancouver
Ding Z, Wang S, Chen J, Song Y, Zhu Z, Tong H, et al. Oridonin targets PRDX1 to promote apoptosis by inducing ROS-mediated ER stress and modulating autophagy. International Journal of Biological Sciences. 2026. doi:10.7150/ijbs.110208
BibTeX
@article{Ding2026,
author = {Ding, Ziyang and Wang, Sisi and Chen, Junhui and Song, Yali and Zhu, Zhou and Tong, Haibo and Iyaswamy, Ashok and Chen, Peng and Wei, Xu and Zhang, Wei and Wang, Jigang and Yang, Chuanbin and Feng, Yulin},
title = {Oridonin targets PRDX1 to promote apoptosis by inducing ROS-mediated ER stress and modulating autophagy},
journal = {International Journal of Biological Sciences},
year = {2026},
doi = {10.7150/ijbs.110208}
}
EUVIMED